For the first time, a federal health panel has recommended against the use of ivermectin for the treatment of COVID-19, despite reports that it’s successfully been used to treat the illness.
In a statement published last week, the National Institute of Health’s COVID-19 Treatment Guidelines Panel said that as the “safety and efficacy of ivermectin for the prevention and treatment of COVID-19 have been evaluated in clinical trials and observational cohorts,” it “recommends against the use of ivermectin for the treatment of COVID-19, except in clinical trials.”